CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--#Europe--AESARA (www.aesara.com) is pleased to announce the appointment of experienced industry market access executive Sameera Tak, MSc, to the European Strategic Partnerships team
TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today
NEW YORK--(BUSINESS WIRE)--Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. Haggstrom brings an extensive background in medical device commercialization and pr
Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by 94% and 99% within 24 and 48 hours of treatment, respectively Median time to a negative PCR test was three days after beginning treatment in the nitric o
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its second quarter 2022 financial results on Tuesday, August 9, 2022, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the s
ONL closed the second tranche of a $46.9 million Series B financing round earlier this year ONL now preparing IND filing for a Phase 2 study of ONL1204 Ophthalmic Solution AmbioPharm providing manufacturing support for ONL1204 NORTH AUGUSTA, S.C. &
Milestone IPA Toxicity Study Supports the Safety of PolyTope® TATX-03 Antibody Cocktail Against COVID-19 IND-enabling safety evaluations of PolyTope® TATX-03, executed under Good Laboratory Practice (GLP) standards and regulatory guidelines, revealed
OTTAWA, Canada & PITTSBURGH--(BUSINESS WIRE)--Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs), and Peptilogics, a biotech company engineering peptide therapeutics by combining c
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that John Dillman has been appointed as the Company
Mr. Dunn is an experienced senior executive with a proven track record of investing in and building highly successful agribusinesses throughout North America and other international jurisdictions VANCOUVER, British Columbia--(BUSINESS WIRE)--Eat Well Inv
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.